Printer Friendly

SYNCOR APPOINTS MICHAEL A PIRAINO AS SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

 CHATSWORTH, Calif., June 7 /PRNewswire/ -- Gene McGrevin, president and chief executive officer of Syncor International Corporation (NASDAQ: SCOR) today announced the appointment of Michael A. Piraino as senior vice president of finance and chief financial officer. Mr. Piraino succeeds Michael Mikity, who will remain with Syncor as a vice president in charge of management information systems, human resources and Syncor's strategic management programs.
 "Michael's appointment is an important step in strengthening the company's senior management team as we address opportunities in the healthcare cost containment field," said Gene McGrevin, president and chief executive officer. "He brings to Syncor a full range of financial management experience and expertise. His diverse skills in financial planning, accounting, accounts receivable management, treasury and operations analysis makes him a key addition to our management team."
 Mr. Piraino brings to Syncor four years of extensive senior management experience in a service oriented high growth healthcare business. Previously, he was senior vice president and chief financial officer of Total Pharmaceutical Care, Inc. (NASDAQ: TPCA).
 Mr. Piraino also has held various key management positions including senior vice president, finance and administrations for Lorimar Home Video and vice president, controller with Winn Enterprises. He gained additional extensive experience in the accounting and healthcare industry through his almost nine years employment with Deloitte & Touche. Piraino obtained the position of senior audit manager and assistant director of the Los Angeles and Orange County healthcare practice at Deloitte & Touche. He graduated from Loyola University with a B.S. degree in accounting and is a registered Certified Public Accountant in the State of California.
 Syncor International Corporation operates an expanding network of 100 nuclear pharmacy service centers. The company compounds and dispenses patient specific intravenous drugs and solutions for use in diagnostic imaging and a complete range of high-tech pharmacy services. Syncor services over 6,000 hospitals, clinics, and physicians' offices. Syncor is the only national pharmacy network of its kind that provides this combination of diagnostic and monitoring services to hospitals and alternate markets.
 -0- 6/7/93
 /CONTACT: Mary L. Meusborn, investor relations of Syncor International Corporation, 818-717-4643, or Bonnie K. Sterling of Noonan/Russo Communications, Inc., 212-979-9180, for Syncor International Corporation/
 (SCOR)


CO: Syncor International Corporation ST: California IN: MTC SU: PER

SH-TS -- NY018 -- 5844 06/07/93 09:07 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 7, 1993
Words:381
Previous Article:BAROID CORPORATION TO ACQUIRE BENTONITE MINING BUSINESS
Next Article:TRANSTECHNOLOGY CORPORATION TO ACQUIRE PALNUT FASTENER OPERATION ON TRW INC.
Topics:


Related Articles
SYNCOR APPOINTS HENRY N. WAGNER, JR., M.D. TO BOARD OF DIRECTORS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters